Patent ID: 9383363
Filing Date: 2016-07-05
CPC Classification: A61B,G01N,H01J

Claim Text:
1. A method for diagnosing urinary bladder transitional cell carcinoma in a human subject suspected of having urinary bladder cancer comprising: (a) obtaining urine from the human subject wherein the human subject does not have urinary tract infection, (b) obtaining a pellet from the urine; and (c) detecting in the pellet the presence or absence of human LASP-1 (LIM and SH3 Domain Protein 1) consisting of the amino acid sequence of SEQ ID NO: 1 by Western Blot analysis, immunohistochemistry, mass spectrometry analysis, FACS analysis or ELISA, wherein the presence of LASP-1 above 1 ng/500 ul of the urine is indicative for urinary bladder transitional cell carcinoma and wherein the urine comprises less than 250 erythrocytes/ul.